HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 26, Nos. 11 & 12, November & December 2022 – Worlds Within Worlds – Viruses, Humanity, and the Environment       » Pinpointing How This Key Protein Facilitates Viral Transmission From Insects to Plants       » A New Approach to Treating Organic Wastewater       » Using Old Plants for New Tricks?       » Using Gas Bubbles as Lenses to View Tissues More Deeply       » Seawater as a Renewable Energy Source       » Generating Oxygen Within Cells
Vol 21, No. 02, February 2017   |   Issue PDF view/purchase
EDITOR'S LETTER
Cancer is the leading cause of mortality in many countries. Due to the latest technology and innovations, there are several ways to stop cancer from spreading. Some types of cancer are preventable or detectable. Many can be treated with early diagnosis and interventions.

National Cancer Centre Singapore (NCCS) provides comprehensive clinical cancer genetic testing to identify individuals at risk of hereditary cancer syndromes across all tumour types. However, low uptake of genetic testing is reported in Asia. At NCCS, there is concern that removing the availability of subsidies could potentially diminish the uptake rate of genetic testing in those who need it. Dr Ngeow et al. relay that efforts to increasing predictive testing rates and implementation of a formal subsidy programme are significant to impact public health. (Refer to “Impact of Subsidies on Genetic Testing Uptake in Singapore: Is it Feasible?")

Dr Lim's article ("Cancer in Women: Trends in Singapore") highlights the increasing incidence of cancers such as breast, ovarian and uterine cancer in females. Despite having effective treatment, breast cancer is still the top cause of cancer death in women. Cervical cancer is the only cancer that has been decreasing in incidence in women in the last recent years.

With the advent of immunotherapy, advanced stage cancer patients are able to keep the disease in track without progression.

In Features section, there are also articles introducing osimertinib (a new drug for advanced lung cancer patients), various tools used by oncologists to fight against cancer and targeted therapies, etc.

Grab a copy of APBN February issue now for your leisure reading, and to keep up to date on news regarding the latest research and breakthroughs in health and biotechnology from all over the world.

Thank you.


Carmen, Jia Wen Loh
APBN Editor
You can reach me at [email protected]

NEWS CRUNCH  
news analytica Vietnam Exhibition Returns to Reunite the Industry After Its 4-Year Hiatus
news 2022 PDA Aseptic Processing of Biopharmaceuticals Conference
news Thailand LAB INTERNATIONAL, Bio Asia Pacific, and FutureCHEM INTERNATIONAL are ready to offer the Science and Technology Industry complete solutions this September!
news Better together: registration opens for Vitafoods Asia 2022 co-located with Fi Asia in October
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   [email protected] or Ms Carmen Chan
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   [email protected]
Copyright© 2022 World Scientific Publishing Co Pte Ltd  •  Privacy Policy